Health utilities in patients with HIV/AIDS in Thailand

Value in Health

Volumn 12, Issue 2, 2009, Pages 377-384

  Sakthong, Phantipa ^a   Schommer, Jon C ^b   Gross, Cynthia R ^b   Prasithsirikul, Wisit ^c   Sakulbumrungsil, Rungpetch ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Bamrasnaradura Infectious Disease Institute   (Thailand)

Author keywords

EQ 5D; Health utility; HIV AIDS; Standard gamble; Visual analog scale

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; HEALTH CARE UTILIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; THAILAND; VISUAL ANALOG SCALE; WORLD HEALTH ORGANIZATION; ANALYSIS OF VARIANCE; CONFIDENCE INTERVAL; HEALTH STATUS; HEALTH STATUS INDICATOR; HIV INFECTIONS; MULTIVARIATE ANALYSIS; NONPARAMETRIC TEST; PAIN MEASUREMENT; PATHOPHYSIOLOGY; PSYCHOLOGY; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE;

ADULT; ANALYSIS OF VARIANCE; CONFIDENCE INTERVALS; FEASIBILITY STUDIES; FEMALE; HEALTH STATUS; HEALTH STATUS INDICATORS; HIV INFECTIONS; HUMANS; MALE; MULTIVARIATE ANALYSIS; PAIN MEASUREMENT; QUALITY OF LIFE; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; STATISTICS, NONPARAMETRIC; THAILAND;

EID: 60349091395     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2008.00440.x     Document Type: Article

References (49)

1. Epidemiology Department, Ministry of Public Health. AIDS situations. Thailand, 2006. Available from: http://epid.moph.go.th [Accessed March 14, 2007].
2. Coons SJ, Kaplan RM. Cost-utility analysis. In : Bottman JL, Townsend RJ, McGhan WF, eds. Principle of Pharmacoeconomics (2nd ed.). Cincinnati, OH : Harvey Whitney Books Company, 1996.
3. Cramer J, Spilker B. Quality of Life and Pharmacoeconomics: an Introduction. Philadelphia : Lippincott-Raven Publishers, 1998.
4. Gold MR, Russell LB, Siegel JE, Weinstein MC. Cost-Effectiveness in Health and Medicine. New York : Oxford University Press, 1996.
5. Drummond ME, Sculpher MJ, Torrance GW, et al. Methods for the Economic Evaluation of Health Care Programmes (3rd ed.). New York : Oxford University Press, 2005.
6. Von Neumann J, Morgenstern O. Theory of Games and Economic Behavior. Princeton, NJ : Princeton University Press, 1944.
7. Arnsen TM, Norheim OF. Quantifying quality of life for economic analysis: time out for time trade off. J Med Ethics 2003 29 : 81 6.
8. Tsevat J, Dawson NV, Wu AW, et al. Health values of hospitalized patients 80 years or older: HELP investigators: Hospitalized Elderly Longitudinal Project. JAMA 1998 279 : 371 5.
9. Center of Disease Control. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recom Rep 1993 41 (no.RR-17).
10. WHOQOL Group. The World Health Organization Quality of Life assessment instrument (WHOQOL): development and general psychometric properties. Soc Sci Med 1998 46 : 1569 85.
11. WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med 1998 28 : 551 8.
12. Mahatnirunkul S, Tuntipivatanakul W, Pumpisanchai W, et al. Comparison of the WHOQOL-100 and the WHOQOL-BREF (26 items). J Ment Health Thai 1998 5 : 4 15.
13. Sakthong P, Schommer JC, Gross CR, et al. Psychometric properties of WHOQOL-BREF-THAI in Patients with HIV/AIDS. J Med Assoc Thai 2007 90 : 2449 60.
14. Cleary PD, Fowler FJ, Weisman J, et al. Health-related quality of life in persons with acquired immune deficiency syndrome. Med Care 1993 31 : 569 80.
15. Cunningham WE, Bozzette SA, Hays RD, et al. Comparison of health-related quality of life in clinical trial and nonclinical trial human immunodeficiency virus-infected cohorts. Med Care 1995 33 : AS15 25.
16. Whalen CC, Antam M, Carey J, et al. An index of symptoms for infection with human immunodeficiency virus: reliability and validity. J Clin Epidemiol 1994 47 : 537 46.
17. Dolan P, Gudex C, Kind P, Williams A. A social tariff for EuroQOL: results from a UK general population survey. Discussion Paper No. 138, Center for Health Economics, University of York, York, 1995.
18. Dolan P, Gudex C, Kind P. The time trade-off method: results from a general population study. Health Econ 1996 5 : 141 54.
19. Torrance GW. Measurement of health state utilities for economic appraisal. J Health Econ 1986 5 : 1 30.
20. Tengs TO, Lin TH. A meta-analysis of utility estimates for HIV/AIDS. Med Decis Making 2002 22 : 475 81.
21. Fang CT, Hsiung PC, Yu CF, et al. Validation of the World Health Organization quality of life instrument in patients with HIV infection. Qual Life Res 2002 11 : 753 62.
22. Nunnally JC Jr. Psychometric Theory (2nd ed.). New York : McGraw-Hill, 1978.
23. Badia X, Monserrat S, Roset M, et al. Feasibility, validity and test-retest reliability of scaling methods for health states: the visual analogue scale and the time trade-off. Qual Life Res 1999 8 : 303 10.
24. Churchill DN, Torrance GW, Taylor DW, et al. Measurement of quality of life in end-stage renal disease: the time trade-off approach. Clin Invest Med 1987 10 : 14 20.
25. Nowels D, McGloin J, Westfall JM, Holcomb S. Validation of the EQ-5D quality of life instrument in patients after myocardial infarction. Qual Life Res 2005 14 : 95 105.
26. Anton SF, Revicki DA. The use of decision analysis in the pharmacoeconomic evaluation of an antidepressant: a cost-effectiveness study of nefazedone. Psychopharmacol Bull 1995 31 : 249 58.
27. Bass EB, Steinberg EP, Pitt HA, et al. Comparison of the rating scale and the standard gamble in measuring patient preferences for outcomes of gallstone disease. Med Decis Making 1994 14 : 307 14.
28. O'Leary JF, Fairclough DL, Jankowski MK, Weeks JC. Comparison of time-tradeoff utilities and rating scale values of cancer patients and their relatives: evidence for a possible plateau relationship. Med Decis Making 1995 15 : 132 7.
29. Read JL, Quinn RJ, Berwick DM, et al. Preferences for health outcomes: comparison of assessment methods. Med Decis Making 1984 4 : 315 29.
30. Schwartz LM, Woloshin S, Black WC, Welch HG. The role of numeracy in understanding the benefits of screening mammography. Ann Intern Med 1997 127 : 966 72.
31. Lin MR, Hwang HF, Chung KP, et al. Rating scale, standard gamble, and time trade-off for people with traumatic spinal cord injuries. Phys Ther 2006 86 : 337 44.
32. Brunner HI, Maker D, Grundland B, et al. Preferences-based measurement of health-related quality of life (HRQL) in children with chronic musculoskeletal disorders (MSKDs). Med Decis Making 2003 23 : 314 22.
33. Cunningham SJ, Hunt NP. A comparison of health state utilities for denofacial deformity as derived from patients and members of the general public. Eur J Orthod 2000 22 : 335 42.
34. Goossens MEJB, Vlaeyen JWS, Rutten-van Molken MPMH, van der Linden SMJP. Patient utilities in chronic musculoskeletal pain: how useful is the standard gamble method? Pain 1998 80 : 365 75.
35. Juniper EF, Norman GR, Cox FM, Roberts JN. Comparison of the standard gamble, rating scale. AQLQ and SF-36 for measuring quality of life in asthma. Eur Respir J 2001 18 : 38 44.
36. Juniper EF, Thompson AK, Roberts JN. Can the standard gamble and rating scale be used to measure quality of life in rhinoconjunctivitis? Comparison with the RQLQ and SF-36. Allergy 2002 57 : 201 6.
37. King JT, Tsevat J, Moossy JJ, Roberts MS. Preference-based quality of life measurement in patients with cervical spondylotic myelopathy. Spine 2004 29 : 1271 80.
38. Moore AD, Clarke AE, Danoff DS, et al. Can health utility measures be used in lupus research? A comparative validation and reliability study of 4 utility indices. J Rheumatol 1999 26 : 1285 90.
39. Ohsawa I, Ishida T, Oshida Y, et al. Subjective health values of individuals with diabetes in Japan: comparison of utility values with the SF-36 scores. Diabetes Res Clin Pract 2003 62 : 9 16.
40. Delate T, Coons SJ. The use of 2 health-related quality of life measures in a sample of persons infected with human immunodeficiency virus. Clin Infect Dis 2001 32 : e47 52.
41. Kaarlola A, Pettila V, Kekki P. Performance of two measures of general health-related quality of life, the EQ-5D and the RAND-36 among critically ill patients. Intensive Care Med 2004 30 : 2245 52.
42. Luo N, Chew LH, Fong KY, et al. Validity and reliability of the EQ-5D self-report questionnaire in English-speaking Asian patients with rheumatic diseases in Singapore. Qual Life Res 2003 12 : 87 92.
43. Marra CA, Woolcott JC, Kopec JA, et al. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D0 and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med 2005 60 : 1571 82.
44. Wu AW, Jacobson DL, Frick KD, et al. Validity and responsiveness of the EuroQOL as a measure of the health-related quality of life in people enrolled in an AIDS clinical trial. Qual Life Res 2002 11 : 273 82.
45. Tsevat J, Sherman SN, McElwee JA, et al. The will to live among HIV-infected patients. Ann Intern Med 1999 131 : 194 8.
46. Revicki DA, Kaplan RM. Relationship between psychometric and utility-based approaches to the measurement of health-related quality of life. Qual Life Res 1993 2 : 477 87.
47. Michalos A. Social indicators research and health-related quality of life research. Soc Indic Res 2004 65 : 27 72.
48. Littenberg B, Partilo S, Licata A, Kattan MW. Paper standard gamble: the reliability of a paper questionnaire to assess utility. Med Decis Making 2003 23 : 480 8.
49. Ross PL, Littenberg B, Fearn P, et al. Paper standard gamble: a paper-based measure of standard gamble utility for current health. Int J Technol Assess Health Care 2003 19 : 135 47.